2016
DOI: 10.1016/j.ahj.2016.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Reactive hyperemia is associated with adverse clinical outcomes in heart failure

Abstract: Introduction Impaired endothelial function, as assessed by brachial artery flow-mediated dilation (FMD), is an established risk factor for cardiovascular events. FMD is impaired in heart failure (HF) patients, but less is known about hyperemic brachial artery flow. We investigated the relationship between FMD and hyperemic flow with adverse clinical outcomes in HF patients. Methods Brachial artery FMD and hyperemic flow were assessed in 156 patients (70.5 % Male; 45.5% Caucasian; mean age (± SD) = 56.2 (± 12… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 35 publications
1
26
0
1
Order By: Relevance
“…For example, modulation of myogenic tone by endothelial-dependent factors differed with sex in murine mesenteric arteries [49] and FMD in skeletal muscle arterioles was greater in females [50]. No sex differences were observed for FMD in a large population-based study [51], nor for FMD or reactive hyperemia in patients with heart failure [52]. Besides the above local regulatory mechanisms, circulating estrogen has cerebral vasodilatory activity, including promotion of eNOS/NO activity and dilatory prostanoids [41, 53] that affect these mechanisms.…”
Section: Discussionmentioning
confidence: 99%
“…For example, modulation of myogenic tone by endothelial-dependent factors differed with sex in murine mesenteric arteries [49] and FMD in skeletal muscle arterioles was greater in females [50]. No sex differences were observed for FMD in a large population-based study [51], nor for FMD or reactive hyperemia in patients with heart failure [52]. Besides the above local regulatory mechanisms, circulating estrogen has cerebral vasodilatory activity, including promotion of eNOS/NO activity and dilatory prostanoids [41, 53] that affect these mechanisms.…”
Section: Discussionmentioning
confidence: 99%
“…2022 On the other hand, Paine et al. 23 did not associate FMD with clinical outcomes in HF patients.…”
Section: Endothelial Dysfunction and Prognosismentioning
confidence: 93%
“…To assess microvascular function, peak velocity during reactive hyperemia (VHR) and shear stress during reactive hyperemia (SSRH) were compared. SSRH was calculated according to the following formula: SSHR (dynes/cm 2 ) = 8 * 0.035 (dynes * s/cm 2 ) * (VRH/(baseline diameter/10)) (19,27,(37)(38)(39)).…”
Section: Measurement Of Brachial Artery Flow Mediated Dilation (Fmd)mentioning
confidence: 99%